Farshchi Jamil 4

4 · EQUIFAX INC · Filed Feb 12, 2026

AI-generated summary of this filing

Updated Feb 12, 2026

Equifax (EFX) CTO Jamil Farshchi Exercises Options, Sells Shares

What Happened

Jamil Farshchi, Executive VP & Chief Technology Officer of Equifax, exercised stock options on Feb 10, 2026 to acquire 6,213 shares at an exercise price basis shown as $191.44 (aggregate value ~$1.19M). The filing also shows immediate dispositions: 3,042 shares were surrendered/used to satisfy tax withholding (reported at $202.71, ~$616,644), and open-market sales of 6,213 shares on Feb 10 for $195.81 ($1,216,568) and 1,167 shares on Feb 11 for $199.87 ($233,248). In addition, Farshchi was credited with a grant of 4,667 restricted stock units (RSUs) (no cash cost shown).

Key Details

Transaction dates & prices:
- 2026-02-10: Exercised 6,213 options @ $191.44 (acquired; value reported $1,189,417).
- 2026-02-10: 3,042 shares withheld/used for taxes @ $202.71 (disposed; $616,644).
- 2026-02-10: Sold 6,213 shares in open market @ $195.81 (disposed; $1,216,568).
- 2026-02-11: Sold 1,167 shares in open market @ $199.87 (disposed; $233,248).
- 2026-02-10: Received grant of 4,667 RSUs (A) @ $0.00.
Sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 4/25/2025 (footnote F1).
Footnotes: F2 notes accrued dividend equivalents reinvested as RSUs and 400 shares from the 2020 ESPP are included in reported holdings; F3 describes the option vesting schedule (vested in three equal annual increments starting 2/21/2021).
Shares owned after the transactions are not specified in the provided excerpt of the filing.
Filing date: 2026-02-12 for transactions on 2026-02-10 and 02-11 — filed within standard reporting window (not marked late).

Context

Codes explained simply: M = option exercise/conversion; F = shares surrendered for tax/payment; S = open-market sale; A = award/grant (RSUs). The pattern here—exercise followed by shares withheld for taxes and open-market sales—is a common way executives realize option gains and meet tax obligations. The reported sales were made under a pre-established 10b5-1 plan, which typically means the trades were pre-scheduled and not ad hoc.

Form 4

Period: 2026-02-10

EVP, Chief Technology Officer

Transactions

Exercise/Conversion
Common Stock
[F1][F2]
2026-02-10$191.44/sh+6,213$1,189,417→ 45,624 total
Award
Common Stock
[F2]
2026-02-10+4,667→ 50,291 total
Tax Payment
Common Stock
[F2]
2026-02-10$202.71/sh−3,042$616,644→ 47,249 total
Sale
Common Stock
[F1][F2]
2026-02-10$195.81/sh−6,213$1,216,568→ 41,036 total
Sale
Common Stock
[F1][F2]
2026-02-11$199.87/sh−1,167$233,248→ 39,869 total
Exercise/Conversion
Stock Option/Right to Buy
[F3]
2026-02-10−6,213→ 0 total
Exercise: $191.44Exp: 2026-02-21→ Common Stock (6,213 underlying)

Footnotes (3)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 4/25/2025.
[F2]Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 400 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.
[F3]The option vested in three equal annual increments beginning 2/21/2021.

Signature

/s/Lisa Stockard as Attorney-in-Fact|2026-02-12

1 file